Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Amlodipine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 105Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Drugs body flags side effects of heart, Glaucoma medications
    Drugs body flags side effects of heart, Glaucoma medications

    06 Jul 2024

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/drugs-body-flags-side-effects-of-heart-glaucoma-medications/articleshow/111522377.cms

    ECONOMIC TIMES
    06 Jul 2024
    Share Share
    Zent2U and Gedeon Richter Expand Access to Amlodipine + Indapamide + Perindopril
    Zent2U and Gedeon Richter Expand Access to Amlodipine + Indapamide + Perindopril

    19 Mar 2024

    // PRESS RELEASE

    https://www.zent2u.com/news/zent2u-and-gedeon-richter-expand-access-amlodipine-indapamide-perindopril

    PRESS RELEASE
    19 Mar 2024
    Share Share
    Amneal's Generic Amlodipine Receives Approval in the U.S.
    Amneal's Generic Amlodipine Receives Approval in the U.S.

    13 Jun 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215035

    FDA
    13 Jun 2023
    Share Share
    Novartis to pay $30 million to health plans, consumers over Exforge antitrus ..
    Novartis to pay $30 million to health plans, consumers over Exforge antitrus ..

    24 Feb 2023

    // HEALTH ET

    https://health.economictimes.indiatimes.com/news/pharma/novartis-to-pay-30-million-to-health-plans-consumers-over-exforge-antitrust-claims/98197879

    HEALTH ET
    24 Feb 2023
    Share Share
    Novartis pays $245M to settle Exforge generic pay-for-delay suit
    Novartis pays $245M to settle Exforge generic pay-for-delay suit

    04 Jan 2023

    // Angus Liu FIERCE PHARMA

    https://www.fiercepharma.com/pharma/novartis-pays-245m-settle-exforge-generic-pay-delay-lawsuits

    Angus Liu FIERCE PHARMA
    04 Jan 2023
    Share Share
    CMP Pharma Announces that Norliqva is Now Available
    CMP Pharma Announces that Norliqva is Now Available

    01 Jun 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/cmp-pharma-inc-announces-that-norliqva-the-first-and-only-fda-approved-liquid-solution-of-amlodipine-is-now-available-301559346.html

    PRNEWSWIRE
    01 Jun 2022
    Share Share